WILLIAM ORTON: Open Payments
NPI 1518019413 · BEAUFORT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 18 payments from 11 companies in 2025. Trend: 2023 $128 · 2024 $154 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $58 |
| ABBVIE INC. | 3 | $52 |
| Astellas Pharma US Inc | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Dexcom G6 Transmitter, VRAYLAR, Veozah, TRINTELLIX, REXULTI, JARDIANCE, ZEPBOUND, FARXIGA.
Industry payments across NC — which companies pay providers there.
